Latest News

Latest News

News from the World Hepatitis Alliance

New research shows indigenous peoples are much more likely to be infected by hepatitis B and/or C

9 Aug 2017 Bridie Taylor

A new meta-analysis of global hepatitis data -- presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska...

Cherokee Nation American Indian Tribe showing it is possible to eliminate hepatitis C

9 Aug 2017 Bridie Taylor

The Cherokee Nation American Indian population is aiming to eliminate hepatitis C virus (HCV) among its tribal citizens, where already almost half...

World Hepatitis Day sets the stage for the elimination of viral hepatitis - Press Release

28 Jul 2017 Tara Farrell

World Hepatitis Alliance calls for greater collaboration to reach 2030 World Health Organization targets...

An open letter to the Cochrane Collaboration

26 Jun 2017 Bridie Taylor

The members of the Executive Board of the World Hepatitis Alliance are elected to represent the more than 300 million people who have the experience...

“Findings from hepatitis C study should not deter patients from seeking treatment or governments from funding it” says World Hepatitis Alliance

13 Jun 2017 Tara Farrell

The World Hepatitis Alliance is concerned that the findings of the Cochrane Review on the new direct acting antiviral (DAA) hepatitis C drugs could...

World Hepatitis Alliance seeks Communications and Campaigns Officer

9 Jun 2017 Tara Farrell

Our dynamic Communications team is seeking an experienced Communications and Campaigns Officer to develop and implement our external facing...

Why do we continue to put our children at unnecessary risk of liver cancer?

6 Jun 2017 Bridie Taylor

On International Children’s Day (1June), the World Hepatitis Alliance calls for widespread coverage of the hepatitis B birth dose vaccine to protect...

WHO’s first Global Hepatitis Report sets baseline to measure progress towards the elimination of viral hepatitis by 2030

21 Apr 2017 Tara Farrell

London, 21 April 2017, The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO). The report comes as a follow-up to WHO’s Global Strategy on Viral Hepatitis, which set a goal of eliminating viral hepatitis as a public health threat by 2030....

ZERO DISCRIMINATION DAY: FEAR AND IGNORANCE ROBS PEOPLE OF JOBS, EDUCATION OPPORTUNITIES, FRIENDSHIPS AND RELATIONSHIPS

1 Mar 2017 Bridie Taylor

People living with viral hepatitis are subject to stigma and discrimination in almost every aspect of their lives. Fear and ignorance have robbed...

World Day of Social Justice: fighting for our right to health

20 Feb 2017 Tara Farrell

By Raquel Peck By the time you finish reading this blog, a man, woman or child will have died from viral hepatitis; a disease which can either be...

World Hepatitis Alliance President-Elect announced

26 Jan 2017 Bridie Taylor

Michael Ninburg appointed as WHA President-Elect Today, the World Hepatitis Alliance (WHA) Executive Board announced that, following a comprehensive...

Elimination to take centre stage at APASL 2017

24 Jan 2017 Bridie Taylor

The elimination of viral hepatitis to dominate discussions at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL...

Industry and civil Society unite to help deliver hepatitis C medication in low-and middle-income countries

18 Jan 2017 Tara Farrell

Today, MasterCard signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore, in a pilot programme, the potential of using the...

India’s young filmmakers give a global voice to viral hepatitis survivors

14 Dec 2016 Tara Farrell

Today, media charity tve today launches four powerful films that give voice to five individuals in India who have survived viral hepatitis, one of...

Leave no-one behind

2 Dec 2016 Tara Farrell

On 3rd December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that patient-centred universal health coverage is...

HIV coinfection more than triples the risk of liver disease, liver failure and liver-related death from viral hepatitis

1 Dec 2016 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2016 –...

New WHA Executive Board announced

28 Nov 2016 Bridie Taylor

Our voting members have spoken and the votes have been counted! Following a fiercely contested election, we are delighted to announce our new...

WHO launches first-ever global report on access to hepatitis C treatment

27 Oct 2016 Tara Farrell

New report from the World Health Organization (WHO) released today shows how political will, civil society advocacy and pricing negotiations are...

Launch of World Hepatitis Day 2016 Report

19 Oct 2016 Tara Farrell

On 28 July 2016, patients, governments, organisations and many others participated the most successful World Hepatitis Day (WHD) to date, with 174...

New database sheds light on generic hep C drugs in low-and middle-income countries and how to access them

13 Oct 2016 Bridie Taylor

To provide information on the intellectual property status of priority medicines in 101 low-and middle-income countries, the Medicines Patent Pool (...

Pages

News from infohep

DAA treatment reduces the risk of death and liver cancer in France

12 Feb 2019 Keith Alcorn
Treatment with direct-acting antivirals (DAAs) reduced the risk of death, liver cancer and death from liver-related causes in French people with...

Tackling HIV and hepatitis C in Europe: towards minimum standards

11 Feb 2019 Gus Cairns
Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in...

Hepatitis C cure does not improve glucose control in type 2 diabetes

7 Feb 2019 Michael Carter
A successful response to hepatitis C virus (HCV) therapy does not result in long-term improvements in glucose metabolism for people with type 2...

Immunotherapy combinations show promise for liver cancer

4 Feb 2019 Liz Highleyman
Checkpoint inhibitor immunotherapy combinations may slow disease progression in people with hepatocellular carcinoma (HCC), according to two small...

Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost

1 Feb 2019 Michael Carter
Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (...

Experimental therapy improves liver health in people with fatty liver disease

31 Jan 2019 Liz Highleyman
NGM282, an experimental fibroblast growth factor analogue, reduced liver fat build-up and the development of scar tissue in people with non-alcoholic...

WHO hepatitis C elimination targets are achievable, model shows – if 51 million treated by 2030

29 Jan 2019 Keith Alcorn
Expanding hepatitis C screening to diagnose 90% of people by 2030, providing treatment to everyone with hepatitis C, scaling up harm reduction and...

HIV infection an independent risk factor for poorer survival from liver cancer

28 Jan 2019 Michael Carter
Infection with HIV is associated with significantly worse survival for people with hepatocellular carcinoma (HCC, the most common type of...

Conditional cash transfers may improve HCV screening and treatment in drug users

22 Jan 2019 Keith Alcorn
Conditional cash transfers – giving money to encourage use of services – may be needed to reach drug users for hepatitis C testing and treatment if...

Barriers to HCV treatment access from the drug user's point of view: stigma, complex lives and damaged veins

16 Jan 2019 Keith Alcorn
Despite access to hepatitis C treatment, many people who inject drugs still perceive numerous barriers to starting treatment, including the...